 |
PDBsum entry 4x6h
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Development of n-(functionalized benzoyl)-homocycloleucyl- glycinonitriles as potent cathepsin k inhibitors.
|
|
Structure:
|
 |
Cathepsin k. Chain: a. Fragment: unp residues 115-329. Synonym: cathepsin o,cathepsin o2,cathepsin x. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ctsk, ctso, ctso2. Expressed in: komagataella pastoris gs115. Expression_system_taxid: 644223
|
|
Resolution:
|
 |
|
1.00Å
|
R-factor:
|
0.155
|
R-free:
|
0.166
|
|
|
Authors:
|
 |
J.Borisek,B.Mohar,M.Vizovisek,P.Sosnowski,D.Turk,B.Turk,M.Novic
|
|
Key ref:
|
 |
J.Borišek
et al.
(2015).
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.
J Med Chem,
58,
6928-6937.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Dec-14
|
Release date:
|
23-Sep-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P43235
(CATK_HUMAN) -
Cathepsin K from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
329 a.a.
215 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.22.38
- cathepsin K.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Broad proteolytic activity. With small-molecule substrates and inhibitors, the major determinant of specificity is P2, which is preferably Leu, Met > Phe, and not Arg.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Med Chem
58:6928-6937
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.
|
|
J.Borišek,
M.Vizovišek,
P.Sosnowski,
B.Turk,
D.Turk,
B.Mohar,
M.Novič.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cathepsin K is a major drug target for osteoporosis and related-bone disorders.
Using a combination of virtual combinatorial chemistry, QSAR modeling, and
molecular docking studies, a series of cathepsin K inhibitors based on
N-(functionalized benzoyl)-homocycloleucyl-glycinonitrile scaffold was
developed. In order to avoid previous problems of cathepsin K inhibitors
associated with lysosomotropism of compounds with basic character that resulted
in off-target effects, a weakly- to nonbasic moiety was incorporated into the P3
position. Compounds 5, 6, and 9 were highly selective for cathepsin K when
compared with cathepsins L and S, with the Ki values in the 10-30 nM range. The
kinetic studies revealed that the new compounds exhibited reversible tight
binding to cathepsin K, while the X-ray structural studies showed covalent and
noncovalent binding between the nitrile group and the catalytic cysteine (Cys25)
site.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |